BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo J, Yi GZ, Liu Z, Sun X, Yang R, Guo M, Li Y, Li K, Li K, Wang X, Song H, Qi S, Huang G, Liu Y. Quantitative Proteomics Analysis Reveals Nuclear Perturbation in Human Glioma U87 Cells treated with Temozolomide. Cell Biochem Funct 2020;38:185-94. [PMID: 31833081 DOI: 10.1002/cbf.3459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Jia J, Ouyang Z, Wang M, Ma W, Liu M, Zhang M, Yu M. MicroRNA-361-5p slows down gliomas development through regulating UBR5 to elevate ATMIN protein expression. Cell Death Dis 2021;12:746. [PMID: 34321465 DOI: 10.1038/s41419-021-04010-1] [Reference Citation Analysis]
2 Lin R, Xu Y, Xie S, Zhang Y, Wang H, Yi G, Huang G, Ni B, Song H, Wang Z, Qi S, Liu Y. Recycling of SLC38A1 to the plasma membrane by DSCR3 promotes acquired temozolomide resistance in glioblastoma. J Neurooncol. [DOI: 10.1007/s11060-022-03964-2] [Reference Citation Analysis]
3 Tomar MS, Kumar A, Srivastava C, Shrivastava A. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim Biophys Acta Rev Cancer 2021;1876:188616. [PMID: 34419533 DOI: 10.1016/j.bbcan.2021.188616] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]